Vericel Corp (VCEL)
46.05
+0.60
(+1.32%)
USD |
NASDAQ |
Apr 26, 16:00
46.05
0.00 (0.00%)
After-Hours: 20:00
Vericel Gross Profit Margin (Quarterly): 74.63% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 74.63% |
| September 30, 2023 | 67.15% |
| June 30, 2023 | 65.20% |
| March 31, 2023 | 64.66% |
| December 31, 2022 | 72.59% |
| September 30, 2022 | 65.45% |
| June 30, 2022 | 61.69% |
| March 31, 2022 | 65.01% |
| December 31, 2021 | 71.51% |
| September 30, 2021 | 64.04% |
| June 30, 2021 | 68.09% |
| March 31, 2021 | 66.49% |
| December 31, 2020 | 74.39% |
| September 30, 2020 | 69.66% |
| June 30, 2020 | 56.73% |
| March 31, 2020 | 62.81% |
| December 31, 2019 | 73.13% |
| September 30, 2019 | 69.43% |
| June 30, 2019 | 65.50% |
| March 31, 2019 | 60.39% |
| December 31, 2018 | 72.46% |
| September 30, 2018 | 63.81% |
| June 30, 2018 | 59.36% |
| March 31, 2018 | 57.47% |
| December 31, 2017 | 64.07% |
| Date | Value |
|---|---|
| September 30, 2017 | 49.61% |
| June 30, 2017 | 54.76% |
| March 31, 2017 | 24.06% |
| December 31, 2016 | 54.06% |
| September 30, 2016 | 37.27% |
| June 30, 2016 | 43.07% |
| March 31, 2016 | 53.50% |
| December 31, 2015 | 53.12% |
| September 30, 2015 | 40.12% |
| June 30, 2015 | 49.22% |
| March 31, 2015 | 48.68% |
| December 31, 2014 | 54.09% |
| September 30, 2014 | 42.72% |
| June 30, 2014 | -13.02% |
| March 31, 2014 | |
| December 31, 2013 | 87.50% |
| September 30, 2013 | |
| June 30, 2013 | 66.67% |
| March 31, 2013 | 75.00% |
| December 31, 2012 | 78.95% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 0.00% |
| December 31, 2011 | |
| September 30, 2011 | 77.78% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
56.73%
Minimum
Jun 2020
74.63%
Maximum
Dec 2023
67.27%
Average
66.49%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Arbutus Biopharma Corp | -- |
| Chimerix Inc | -- |
| Karyopharm Therapeutics Inc | 95.60% |
| Axsome Therapeutics Inc | 89.69% |
| Y-mAbs Therapeutics Inc | 91.27% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.57% |
| Return on Assets | -1.05% |
| Return on Invested Capital | -1.57% |
| Profit Margin (Quarterly) | 19.99% |
| Operating Margin (Quarterly) | 19.59% |
| Return on Net Operating Assets | -2.09% |